Abstract From July 1971 to August 1975, 63 previously untreated patients with stage IV non-
Hodgkin's lymphomas with favorable histologies were prospectively randomized to three …

Abstract Between 1975 and 1978, 51 patients with favorable histology non-Hodgkin's
lymphomas, pathologic stage III-IV, were treated prospectively on a randomized treatment …

Therapy for aggressive non‐Hodgkin's lymphomas has undergone significant evolution in
the last 25 years. First generation combination chemotherapy studies produced complete …

SUMMARY The Stanford University chemotherapy experience in the non-Hodgkin's
lymphomas includes a prospective randomized trial in patients with stage IV disease and …

Ninety-five patients with advanced non-Hodgkin's lymphoma were treated with four courses
of cyclophosphamide, adriamycin, vincristine and prednisone, with or without procarbazine …

Previous studies have established CHOP (cyclophosphamide, doxorubicin, vincristine,
prednisone) as the standard of comparison for treatment programs for patients with …

In a randomized, prospective trial from 1974–1978, 73 patients with non‐Hodgkin's
lymphomas in clinical Stage I or II were treated with extended field radiotherapy alone (RT) …

Ninety-nine previously untreated patients with stage III and IV malignant lymphoma were
randomized to receive either cyclic combination chemotherapy (50 patients) or extensive" …

Abstract Treatment results were reviewed in 473 consecutively staged and treated patients
at the National Cancer Institute over a 22‐year period from 1953 to 1975. Responses …

Between July 1, 1971 and December 31, 1978, 150 patients with favorable subtypes of non-
Hodgkin's lymphoma [nodular poorly differentiated lymphocytic (NLPD), nodular mixed, or …